Agenus, Inc. (AGEN)
3.40
+0.06
(+1.80%)
USD |
NASDAQ |
Apr 01, 16:00
3.33
-0.07
(-2.06%)
Pre-Market: 09:20
Agenus Research and Development Expense (TTM) : 79.34M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Protalix Biotherapeutics, Inc. | 19.57M |
| CervoMed, Inc. | 21.82M |
| Curis, Inc. | 28.25M |
| Plus Therapeutics, Inc. | 8.379M |
| Windtree Therapeutics, Inc. | 8.129M |